Galderma Group
CHF 160.55Change from previous close: −0.16%Absolute change: −CHF 0.25
Company profile
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Switzerland
- Headquarters
- Zählerweg 10, 6300, Zug
- Employees
- 7,676
- Chief executive
- Flemming Ornskov
- Founded
- 1981
- Fiscal year
- January - December
- Listing
- GALD · SIX
- Indices
- SMI
- Currency
- CHF
- ISIN
- CH1335392721
- Website
- galderma.com